PT Kalbe Farma Tbk (KLBF) terus memperkuat pasar ekspor ke berbagai negara Asia, Timur Tengah hingga Afrika dalam meningkatkan kinerja perseroan. Selain itu, perseroan memperkuat penetrasi obat-obatan onkologi di Asia Tenggara dengan membentuk kemitraan yang strategis.
Category
📺
TVTranscript
00:00We move on to information on the selection committee where PTKB Pharma TBK or KLBF continues to strengthen the export market to various Asian countries from the Middle East to Africa in increasing the production of heroin.
00:17In addition, heroin strengthens the penetration of oncology drugs in Southeast Asia by forming strategic partnerships.
00:24According to the media, PTKB Pharma TBK or KLBF explained today that the export contribution of heroin is around 5-6% of the total sales.
00:40From the strategy side, heroin is focused on exporting to countries and building a marketing team as well as carrying out joint distribution in local countries.
00:50Heroin is currently strengthening exports to Southeast Asian countries, adding exports to Sri Lanka and several countries in the Middle East and South Africa as well as Nigeria.
01:02Heroin emphasizes that the product of KLB Pharma can be accessed to more than 40 countries in the ASEAN region, East Asia, South Asia, Middle East and Africa.
01:13This makes Perseran a national health product company that is able to compete in the international market.
01:19In addition, Perseran took steps to strengthen the penetration of oncology drugs in Southeast Asia and form strategic partnerships with Alliance Pharma Thailand.
01:30To be known, Perseran recorded a growth of 18.4% per year to 1.8 trillion rupiah in semester 1 2024.
01:41This increase is supported by the entire business segment with good operational cost management.
01:46In addition, sales grew by 7.6% to 16.3 trillion rupiah.
01:52The decrease in the price of raw materials and operational cost management continues to support the increase.
01:57Various IDX Channel Sources
02:27Viewing the graphics on your television screen, viewers, the closure at the end of last week, exactly on September 6, KLBF closed at Rp 1,710.
02:36Opened flat this morning at the same level, but after the opening, KLBF experienced significant strength and reached the highest intraday level today at Rp 1,755.
02:48From Rp 1,740 to Rp 1,735 with the closure of the first session this afternoon, the strength is more towards the limit, as well as the position of the opening of the second session.
03:00Thin strength at Rp 1,730 compared to the closing position in the first session this afternoon.
03:07Currently, the position of KLBF is still moving in the green zone, but the strength is only at 0.88% when it was intraday today, it was stronger than 1%.
03:18The position is Rp 1,725.
03:21We move on to the next graph, how has the movement of KLBF stocks in the last few months, where KLBF has experienced significant strength, viewers.
03:31In the early April trading, KLBF was still moving at the Rp 1,400 level, precisely at Rp 1,465.
03:38On May 27, it strengthened to Rp 1,565 and in June at Rp 1,600.
03:45However, in the July trading, KLBF stocks were again under pressure, far below Rp 1,600, precisely at Rp 1,440.
03:54However, between July and August, KLBF stocks tried to rise, even to the highest intraday level, Rp 1,755.
04:02During today's trading, the highest intraday was Rp 6,000 and also year-to-date.
04:07Although in the opening of the second session, the strength was more limited at Rp 1,730 and currently at Rp 1,725.
04:14How about the valuation with some indicators? Viewers, the next graph is also on your television screen.
04:23The price-to-earning ratio is around 22.53x, PSR at 2.49x, PBV at 3.73x, and PCFR at 17.15x.
04:34A combination of fundamental, technical, and also on the valuation side, and hopefully it can be one of your references.
04:41We will meet again and stay in your place.
04:44After this, we will review how the trading has been going on throughout the day,
04:48especially in rural areas that have experienced quite a deep correction.
04:52We will be back in a moment.